A Pilot Study To Establish an In Vitro Model To Study Premature Intestinal Epithelium and Gut Microbiota Interactions

Justin Gibbons1,2, Ji Youn Yoo3, Tina Mutka4

  • 1Center for Global Health and Infectious Diseases, College of Public Health, University of South Floridagrid.170693.a, Tampa, Florida, USA.

Msphere
|October 13, 2021
PubMed

Insights

This study developed an in vitro model using fetal intestinal cells and preterm infant stool to study gut microbiota interactions. Findings revealed correlations between specific bacterial ratios and infant inflammatory responses.

Area of Science:

  • Microbiology
  • Gastroenterology
  • Neonatology

Background:

  • Intestinal microbiota plays a crucial role in preterm infant health and disease.
  • Interactions between gut flora and the intestinal epithelium can cause local injury and systemic illness.
  • Current in vitro models often use adult cells or single organisms, limiting their applicability to preterm infants.

Purpose of the Study:

  • To develop and validate an in vitro cell model using fetal intestinal cells exposed to preterm infant fecal filtrates.
  • To investigate the relationship between intestinal microbiota composition and epithelial responses in preterm infants.
  • To analyze cytokine production and gene expression in fetal epithelial cells upon exposure to diverse microbial environments.

Main Methods:

  • Exposure of FHs-74 int fetal epithelial cell cultures to sterile fecal filtrates from preterm infants.
  • Measurement of cytokine levels in culture media at 4, 24, and 48 hours.
  • Analysis of 16S rRNA gene sequencing for fecal microbiota and RNA-sequencing for epithelial cell gene expression.

Main Results:

  • Identified correlations between the Proteobacteria-to-Firmicutes ratio and inflammatory cytokine levels.
  • Found associations between specific fecal bacterial genera and epithelial apoptosis-related gene expression.
  • Demonstrated the utility of the in vitro model in reflecting host-microbe interactions relevant to preterm infants.

Conclusions:

  • The developed in vitro model effectively simulates preterm infant gut conditions, enabling the study of host-microbe interactions.
  • This model provides insights into the mechanisms underlying inflammatory responses and epithelial changes in preterm infants.
  • The model holds potential for personalized medicine approaches by utilizing patient-derived cells and microbiota.

Related Concept Videos